Mergers and Big Decisions
02/18/2019 | George Chressanthis, Randy Risser
Why the CVS-Aetna merger could be a transformative event for the pharmaceutical industry.
Phasing Out Inefficiency
02/21/2019 | Simon Tyler
Struggling with process research and development? Find yourself a CRO that knows what it’s doing.
The Elderly Are the Future
02/21/2019 | Erin O’Brien, Chris Evans
Drug delivery devices must take into account the needs of older adults.
Taste the Rainbow
02/20/2019 | Nicolas Madit
The color of a capsule or tablet can have a big impact on compliance and branding. To avoid delays, early decisions have to be made.
Click below for the latest print issue
Download the PDF
New Year; New Therapies

Have you caught up with Gene and Eva’s latest (mis)adventure?

See more
Passionate. Driven. Impactful.

The Translational Scientist sits at the leading edge of bench-to-bedside research, celebrating translation today – and exploring the inside track on the innovations set to revolutionize tomorrow...

Read The Newsletter
On-Demand Webinar
“I want it all, and I want it now,” a study on the future of filling

Innovative fill lines combine the activities that would traditionally be three separate filling lines into one line under barrier isolation in a single filling suite. Join CRB for a webinar exploring how these highly touted, faster and more efficient lines could impact the industry.

White Papers
Exploring the rigor and requirements of Analytical Quality by Design
02/06/2018 | Contributed by Malvern Panalytical
The application of QbD has become second nature to the pharmaceutical industry
Top five ways of improving the stability of your formulation
02/06/2018 | Contributed by Malvern Panalytical
Using the Zetasizer Nano to optimize formulation stability
Special Promo

Bioprocessing application notebook - The best purification methods for your biomolecules


Discover over twenty application notes on biopharmaceutical purification – capturing of antibody constructs such as Fab or scFv, mAb aggregate removal using salt-tolerant IEC or hydroxyapatite, intermediate purification of bi-specific antibodies with a non-affinity platform using MXC and HIC, ADC purification, highly-selective AEX separation of oligonucleotides, and many more!

Read more!
In Conversation with Nick Shackley of Johnson Matthey

The Medicine Maker's James Strachan met with business leaders and specialists to discuss the latest innovations and trends in pharmaceutical manufacturing. Here, James speaks with Nick Shackley, VP of Johnson Matthey.

Watch More

Be it a large congress at a huge venue or an expert meeting that fits around a table, these events are a fantastic way to network and educate yourself on the latest developments in the industry – so why not take a look at our list of upcoming events?

More Information